BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+7.23%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.3T
AUM Growth
+$134B
(+6.2%)
Cap. Flow
+$6.59B
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
5,139
New
111
Increased
3,068
Reduced
1,215
Closed
138
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.58B |
| 2 |
iShares Global 100 ETF
IOO
|
+$1.12B |
| 3 |
Williams Companies
WMB
|
+$917M |
| 4 |
iShares Europe ETF
IEV
|
+$554M |
| 5 |
Prologis
PLD
|
+$540M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.6B |
| 2 |
GGP
GGP Inc.
GGP
|
+$1.17B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
SPDR Gold Trust
GLD
|
+$1.05B |
| 5 |
XL
XL Group Ltd.
XL
|
+$1.05B |
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Financials | 14.52% |
| 3 | Healthcare | 14.13% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Arbor Realty Trust
ABR
$2.25B
| $74.4M | ﹤0.01% |
6,484,367
+514,809
| +9% | +$5.91M |
|
|
MRTX
2152
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $74.4M | ﹤0.01% |
1,578,852
+127,638
| +9% | +$6.01M |
|
2153
Red Robin
RRGB
$121M
| $74.4M | ﹤0.01% |
1,852,075
+82,313
| +5% | +$3.3M |
|
2154
Huron Consulting
HURN
$2.44B
| $74.3M | ﹤0.01% |
1,503,503
+13,350
| +0.9% | +$659K |
|
2155
iShares S&P India Nifty 50 Index Fund
INDY
$652M
| $74.1M | ﹤0.01% |
2,168,095
+32,613
| +2% | +$1.12M |
|
|
INST
2156
DELISTED
Instructure, Inc.
INST
| $73.6M | ﹤0.01% |
2,078,146
+29,612
| +1% | +$1.05M |
|
2157
iShares MSCI South Korea ETF
EWY
$5.52B
| $73.5M | ﹤0.01% |
1,076,583
+403,914
| +60% | +$27.6M |
|
2158
KT
KT
$9.52B
| $73.2M | ﹤0.01% |
4,928,999
+1,403,146
| +40% | +$20.8M |
|
2159
AppFolio
APPF
$9.9B
| $73.1M | ﹤0.01% |
932,112
+37,125
| +4% | +$2.91M |
|
2160
AMC Entertainment Holdings
AMC
$1.44B
| $73M | ﹤0.01% |
356,322
+10,312
| +3% | +$2.11M |
|
|
FSB
2161
DELISTED
Franklin Financial Network, Inc.
FSB
| $73M | ﹤0.01% |
1,867,326
+99,452
| +6% | +$3.89M |
|
|
ASXC
2162
DELISTED
Asensus Surgical, Inc.
ASXC
| $72.9M | ﹤0.01% |
967,365
+208,091
| +27% | +$15.7M |
|
2163
Karyopharm Therapeutics
KPTI
$55.9M
| $72.6M | ﹤0.01% |
284,035
+13,659
| +5% | +$3.49M |
|
2164
IMAX
IMAX
$1.74B
| $72.5M | ﹤0.01% |
2,811,391
-51,515
| -2% | -$1.33M |
|
|
KMG
2165
DELISTED
KMG Chemicals Inc
KMG
| $72.5M | ﹤0.01% |
959,623
-19,128
| -2% | -$1.45M |
|
2166
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $72.5M | ﹤0.01% |
1,737,961
+464,691
| +36% | +$19.4M |
|
2167
Ichor Holdings
ICHR
$579M
| $72.4M | ﹤0.01% |
3,545,139
+1,941,439
| +121% | +$39.6M |
|
2168
SPDR S&P Global Natural Resources ETF
GNR
$3.32B
| $72.4M | ﹤0.01% |
1,430,985
+17,668
| +1% | +$893K |
|
2169
Clearwater Paper
CLW
$344M
| $72.3M | ﹤0.01% |
2,435,673
+108,439
| +5% | +$3.22M |
|
2170
Constellium
CSTM
$2.08B
| $72.3M | ﹤0.01% |
5,857,178
-68,152
| -1% | -$842K |
|
|
TWNK
2171
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $72.2M | ﹤0.01% |
6,522,238
+164,402
| +3% | +$1.82M |
|
2172
Marcus & Millichap
MMI
$1.26B
| $71.9M | ﹤0.01% |
2,071,988
+128,483
| +7% | +$4.46M |
|
2173
Denali Therapeutics
DNLI
$2.07B
| $71.9M | ﹤0.01% |
3,307,050
+2,185,692
| +195% | +$47.5M |
|
2174
MasterCraft Boat Holdings
MCFT
$362M
| $71.8M | ﹤0.01% |
2,001,117
-264,236
| -12% | -$9.48M |
|
2175
CytomX Therapeutics
CTMX
$330M
| $71.6M | ﹤0.01% |
3,868,566
+642,165
| +20% | +$11.9M |
|